Login   Contact Us      
RemitDATA - Gets what coming to you

Improve Your Reimbursement Results

Serum versus Plasma

Take Control of Your Medicare A/R

Staff Feedback Pays Dividends

Boost Cash Flow by Tracking DSO

Pharmacy Quality Standards

Billing Specialists Get The Job Done

Should you Part D

The Right Team Makes A Great Company

The Importance of Proper Aseptic Technique

The Answers Are in Your Data

Synercid

Inside the 835 - Part 1 - CR Codes

Treating an Unhealthy Accounts Receivable

Are You Compounding or Manufacturing?

Prepare For Bad Debt Reserves

Maximizing Your Value in Mergers and Acquisitions

Is Outsourcing Right For You?

Team Talent is Essential

What's the Value of Your Business

Inside the 835: Part 2--Medicare Codes

Pharmacists Recognized As A Provider:

Part D Success Story: $24K Denied, Then Reversed

Maximize Revenue On Rental Equipment

Leverage Points: Mission and Vision

The Value of Therapeutic Drug Monitoring

Listserv Lessons: Post-dose Vancomycin peak draws

Take Control of Your Patient Receivables

Acquisition Strategy – Securing Management

Pedigree Provisions: A New Responsibility

Cash is still King

Listserv Lessons: Patient Financial Responsibility

HEMOLYSIS - CAUSE AND EFFECT

Who's tracking YOUR sales?

Five Approaches to Training a Sales Person

CASH FLOW: Shows Your Company’s True Health

NPI Deadline is May 23 - Are you ready?

Listserv Lessons: Billing Per Diems on Non-Infused

Microalbumin

Credit Balances, an overlooked problem

Managing Open Invoices

Listserv Lessons: Insurance Company defining AWP

Revenue Recognition: Are You Collecting 95%?

BitLeap's online, offsite data backup system

Is NHIC getting The Job Done?

Drug of the Month - Infliximab

Sed.Rate and C-Reative Protein Assay

A Systemic Approach to Purchasing Negotiations

A Systemic Approach to Purchasing Negotiations 2

Practical Approach to Physician Credentialing

Is Noridian Getting The Job Done?

The Pharmacist’s Awareness of “Drug Induced Diseas

Listserv Lessons: Medicare Billing Split between M

Glycosylated Hemoglobin

Drug of the Month – Daptomycin (Cubicin®)

Using Denial Tracking to Improve Cash Flow and Sta

Dealing with Denial Code 204 (Replacment for PR 96

The Medicare Program: A Brief Overview

ListServ Lessons: Power PICC Flushing Protocols

Can a blood test predict a heart attack?

Software Implementations - do it perfect the first

Drug of the Month – Lynezolid (Zyvox®)

Add a second monitor to your laptop / desktop

Software implementations – it’s a great time to be

Extreme Drug-Resistant Tuberculosis

Listserv Lessons: Home Infusion Pharmacy vs Specia

Patient Satisfaction Scores

Managing your payer pricing files

Leadership: An Analysis

Listserv Lessons: Enteral Practice Standards

MRSA on the Rise

Using Clinicians to Improve Reimbursement

Software Implementations: Multi-site conversions

System Management: Managing Serialized Inventory

So, you have a payer contract…or do you?

Questions and Answers about Lyme Disease

Listserv Lessons: Timely Filing and Patient Debt O

System Implementation: 5 Phases of Information Sy

Managing your Windows Desktop

Insurance Companies Play to Win ... you should too

Blood Culture Contamination

KVO’s on Intermittent Pump Infusions

So, the nice lady at Medicare told you that it wou

Listserv Lessons: Huber Needle Changes

ListServ Lessons: Compounding Question

How many billers necessary to change a light bulb?

Listserv Lessons: Monitoring Shipping

Use of Routine ABNs

Investigating Reimbursement Issues

Repackaging your managed care strategy

Managing your Shared Contract Files

Stale A/R on Legacy Systems – Is It Really Worth I

ListServ Lessons - Infusion of Specialty Meds

Know Who Your Patients Are and Where They Are Comi

Know who your patients are and where they are comi

Patient Pay Accounts - If you can't measure it, yo

Those Pesky Rascals

The Care and Feeding of Your Item Master File

Billing Staff Measurement and Feedback

This Call May be Monitored for Quality Assurance

The Price is Right…Or Maybe Not

Using Time & Motion Studies to Improve Pharmacy Pr

Those Pesky Rascals

By Russell Gay
Wednesday, August 12, 2009

Business had taken me from home one chilly evening and I was long asleep when I got a frantic 1 a.m. call -it’s my bride.
“Someone is on the roof” she exclaims with intense trepidation. 
Shaking the cobwebs of my Excedrin PM induced slumber and rolling over the post-
Christmas possibilities, I asked “who would be on our roof”?
Silence, then “He’s walking” she adds and then more listening silence. “There’s more than one”.
Hmmm, a family of rooftop burglars? With no easy house entrance, I wonder about the perpetrators.
“Honey it sounds like cat burglars. Do we still have that Y2K cache of tuna”?
Click, minutes go by, ring, static filled reception that I recognize from a straining remote phone.
“I’m outside” her hushed voice filled with determined bravery, “I’m in my nightgown, with a flashlight”.
“Has that run them off”, I innocently inquired. Ignoring me, she adds “I’ve got a weapon”.
Ok, you now have my full attention. Adrenaline climbing, I’m imagining various options in our limited family arsenal
and what I should do 1,000 miles away when she adds, “I’ve got a boat paddle”.
Whew, cancel the ADT security system, the posse and the SWAT team. Lady in a nightgown with a boat paddle shining a light on the roof, hope the neighbors are getting this on video.
Phone rings, I hadn’t noticed that it was disconnected. A boisterous voice announces, “It’s a family of raccoons”.
The raccoons were trying to keep their babies warm in the wind swept evening by huddling around the still warm chimney.
“You should see them. They are really cute…but loud”.

The loud sounding rascals remind me of our latest industry neighbors, PBMs. As their habitat has become less hospitable they have searched for more promising abodes. As Medicare D PDPs, PBMs developed quite a bit of analysis on infusion providers.  Entry by Medco, expansion by Walgreens and the recent retreat by Express Scripts in the infusion therapy market show their perception of opportunity as well as their challenge in providing a higher-touch product to patients.

PBMs have driven great efficiencies in the prescription drug benefit but their robotic mail-order dispensing, phone tree customer service, transparency issues and their poor image with physicians has road blocked their initial market entry into direct care for patients. But do no discount the wiles of those trying to get into the house.

PBMs are by far the largest providers in specialty infusion niches such as hemophilia. They did this by using a non-PBM service model for the bleeding disorder community and distancing themselves from the corporate headquarters. At a national hemophilia conference that I attended in May, there was great interest and riotous response as an executive dismissed his company’s ownership ties by one of the nation’s largest PBMs. Another PBM choose not to distribute a press release after acquiring an infusion company, allowing the subsidiary to assimilate while retaining its original name. 

And workman’s compensation plans and health plans are beginning to listen. 

I attended a PBM conference where 2 speakers encouraged the largely payor audience to open up traditional medical benefits to PBM administration to drive down costs. No surprise here but then each separately added that they estimated that health plans could save 10% off their total infusion therapy spend by eliminating false and fraudulent claims by infusion providers. No evidence of fraud by providers was produced but you could tell by looking at the audience that a subtle point had been driven home, traditional infusion providers are either sloppy or devious.

There is no discounting that PBMs generally have closer and more exclusive ties with payors. PBMs can point to claim efficiencies and some now have subsidiaries that can perform outsource claim adjudication for the health plan. Others can point to a national footprint to encourage national contracts or note your infusion company’s participation in their Medicare D network as reason why the PBM can more effectively administer an ancillary network. These features are creating some noise.

There is a course that you can take now. Your paddle and flashlight arsenal include:

1. Seeking out an independent and transparent PBM in your area and discuss comarketing to bring efficiencies to your payor customers.

2. Work closely with your largest payor customer Accounts Payable Managers to clean up claims. These loud voices within the health plans have a remarkable influence on your continued participation. A large payor in Indiana took me aside and told me that our bringing a local provider to the table with it’s A/P and Audit Team kept them from sending an already drafted termination notice that would have closed the provider’s operations in that state.

3. If those HCFA 1500s are piling up in the uncollected box, this may be a signal from the payor that they are having coding issues with one of your offices. Visit with Pete or Mandy at Rock-Pond about how your branch can be streamlined to lower A/R and avoid additional headcount.

4. Ask the health plans for risk collaboration in return for greater exclusivity or a percentage of the savings. As an example, substitute your Case Manager and ‘one-stop service model’ for one that the health plan is outsourcing.

5. Promote yourself to payors. You represent $1 of every $100 reimbursed every month for every plan patient. Show them how you impact their members and save them money. If you are challenged on developing an economic analysis then focus on developing case studies of how your company’s unique intervention, staff experience and programs kept members out of the acute care facility, reduced drug waste, returned patients back to work...summarize with real dollars saved.

Your success in a competitive market largely depends on the light that you shine on problems, your impartial assessment and the paddle you wield to win.

These proposals can be a bit challenging if your managed care team doesn’t have much experience in developing these relationships.

2020 ConsultRx has over 20 years experience building collaboration between our clients and payors. Please give me a call and let’s discuss at no obligation, how we can build your business today. Russell.gay@2020consultrx.com or call me at 501-247-1341.


Russell Gay
2020 ConsultRx, LLC
Principal
Russell.gay@2020ConsultRx.com


Download Article

Russell Gay


View all articles by Russell Gay


2020 ConsultRx, LLC


View all articles by 2020 ConsultRx, LLC

 
 


Copyright © 2010 Rock-Pond Solutions. All Rights Reserved.